Skip to content

The effect of melatonin on cognitive function, after coronary artery bypass grafting surgery.

The effect of melatonin on cognitive function, after coronary artery bypass grafting surgery.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141009019470N77
Enrollment
50
Registered
2019-03-03
Start date
2019-03-11
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Grafting Surgery.. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Intervention group: Patients received two oral capsules of melatonin 5 mg daily made by (Super Natural ,Canada)from four weeks prior to surgery and up to two days after surgery. Int

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 40-75 years Patients who are undergoing elective Cardio pulmonary artery bypass grafting.

Exclusion criteria

Exclusion criteria: Acute recent Myocardial Infarction (less than 3 month) Aortic atheromatosis Renal dysfunction; Peripheral vascular disease; Pump time more than 90 min; Corticosteroid therapy since 1 month ago; infection less than 4 weeks ago; Breast feeding Pregnancy; Dementia; Psychiatric disorders Using Benzodiazepines and opioid; Alcohol abuse Hepatic insufficiency Non sinus ECG; Concomitant cardiac surgery; Anticoagulation therapy with warfarin ASA higher than 3 Ejection Fraction less than 45% Severe pulmonary disease Cerebrovascular disease Immunologic disorders Re-operation Emergency operation

Design outcomes

Primary

MeasureTime frame
Cognitive function. Timepoint: 4 weeks before surgery,2 days after surgery and 6 weeks after melatonin administration. Method of measurement: Cognitive function Test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKambiz Zohori

Shiraz University of Medical Sciences

kambiz.zohori@yahoo.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026